154 related articles for article (PubMed ID: 16360447)
1. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
Chan JM; Elkin EP; Silva SJ; Broering JM; Latini DM; Carroll PR
Urology; 2005 Dec; 66(6):1223-8. PubMed ID: 16360447
[TBL] [Abstract][Full Text] [Related]
2. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
3. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
[TBL] [Abstract][Full Text] [Related]
4. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
5. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
[TBL] [Abstract][Full Text] [Related]
6. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
7. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
Can G; Erol O; Aydiner A; Topuz E
Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
[TBL] [Abstract][Full Text] [Related]
9. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
10. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
Cooperberg MR; Broering JM; Litwin MS; Lubeck DP; Mehta SS; Henning JM; Carroll PR;
J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
12. Men with prostate cancer: making decisions about complementary/alternative medicine.
Boon H; Brown JB; Gavin A; Westlake K
Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation.
Porter M; Kolva E; Ahl R; Diefenbach MA
Complement Ther Med; 2008 Dec; 16(6):318-24. PubMed ID: 19028331
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of the use of alternative therapies by men with localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
[TBL] [Abstract][Full Text] [Related]
15. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.
Ryan CJ; Elkin EP; Small EJ; Duchane J; Carroll P
Urol Oncol; 2006; 24(5):396-402. PubMed ID: 16962488
[TBL] [Abstract][Full Text] [Related]
16. Herb and supplement use in the US adult population.
Kennedy J
Clin Ther; 2005 Nov; 27(11):1847-58. PubMed ID: 16368456
[TBL] [Abstract][Full Text] [Related]
17. Use of complementary medicinal therapies in West Pomerania: a population-based study.
Schwarz S; Messerschmidt H; Völzke H; Hoffmann W; Lucht M; Dören M
Climacteric; 2008 Apr; 11(2):124-34. PubMed ID: 18365855
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
Dall'era MA; Hosang N; Konety B; Cowan JE; Carroll PR
J Urol; 2009 Apr; 181(4):1622-7; discussion 1627. PubMed ID: 19230923
[TBL] [Abstract][Full Text] [Related]
19. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE.
Abouassaly R; Paciorek A; Ryan CJ; Carroll PR; Klein EA
Cancer; 2009 Oct; 115(19):4470-6. PubMed ID: 19637339
[TBL] [Abstract][Full Text] [Related]
20. Self-reported health symptoms and conditions among complementary and alternative medicine users in a large military cohort.
Jacobson IG; White MR; Smith TC; Smith B; Wells TS; Gackstetter GD; Boyko EJ;
Ann Epidemiol; 2009 Sep; 19(9):613-22. PubMed ID: 19596206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
